애브비(주)
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionViawealth, Llc
Latest Disclosed Ownership13,318 shares
Latest Disclosed Value $ 2,896,584
Viawealth, Llc reports 0.26% increase in ownership of ABBV / AbbVie Inc.

On May 11, 2026 - Viawealth, Llc filed a 13F-HR form disclosing ownership of 13,318 shares of AbbVie Inc. (US:ABBV) valued at $2,896,532 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 13,284 shares of AbbVie Inc.. This represents a change in shares of 0.26% during the quarter. The current value of the position is $2,995,751 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 13,318 34 0.26 2,897 -4.58 1.6123
2026-02-10 2025-12-31 13F ABBVIE COM 00287Y109 13,284 -734 -5.24 3,035 -6.47 1.7070
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 14,018 214 1.55 3,246 26.66 1.7727
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 13,804 -643 -4.45 2,562 -15.36 1.5148
2025-05-07 2025-03-31 13F ABBVIE COM 00287Y109 14,447 -304 -2.06 3,027 15.49 1.8686
2025-02-11 2024-12-31 13F ABBVIE COM 00287Y109 14,751 -48 -0.32 2,621 -10.30 1.5825
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 14,799 54 0.37 2,922 15.54 1.7032
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 14,745 728 5.19 2,529 -0.90 1.5689
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 14,017 183 1.32 2,553 19.09 1.5960
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 13,834 628 4.76 2,144 8.89 1.4738
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 13,206 1,671 14.49 1,968 26.64 1.4455
2023-08-10 2023-06-30 13F ABBVIE COM 00287Y109 11,535 152 1.34 1,554 -14.29 1.1594
2023-05-12 2023-03-31 13F ABBVIE COM 00287Y109 11,383 16 0.14 1,814 -1.31 1.4370
2023-02-13 2022-12-31 13F ABBVIE COM 00287Y109 11,367 11,367 1,838 1.5118
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.